We are live on ! Find out more
Jane Street

Jane Street Portfolio holdings

AUM $777B
1-Year Est. Return 61.18%
 

Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.

This Fund
S&P 500
This Quarter Est. Return
+8.57%
1 Year Est. Return
+61.18%
3 Year Est. Return
+147.64%
5 Year Est. Return
+157.48%
10 Year Est. Return
+673.77%
AUM
$201B
AUM Growth
+$2.1B
Cap. Flow
-$1.64B
Cap. Flow %
-0.81%
Top 10 Hldgs %
31.57%
Holding
10,046
New
2,632
Increased
3,317
Reduced
3,042
Closed
1,017

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 2.84%
2 Communication Services 2.06%
3 Technology 2%
4 Healthcare 1.06%
5 Financials 0.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VKTX icon
7776
PUT
Viking Therapeutics
VKTX
$4.02B
$274K ﹤0.01%
43,300
+26,500
+158% +$186K
SURF
7777
PUT
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$274K ﹤0.01%
+35,100
New +$351K
SPRQ.U
7778
DELISTED
Spartan Acquisition Corp. II Units, each consisting of one share of Class A common stock, and one-ha
SPRQ.U
$274K ﹤0.01%
24,116
-175,884
-88% -$2.21M
AKBA icon
7779
CALL
Akebia Therapeutics
AKBA
$234M
$273K ﹤0.01%
80,700
+16,600
+26% +$59.8K
CRBP icon
7780
CALL
Corbus Pharmaceuticals
CRBP
$177M
$273K ﹤0.01%
4,620
-2,567
-36% -$169K
EQH icon
7781
Equitable Holdings
EQH
$14.4B
$273K ﹤0.01%
8,383
-60,704
-88% -$1.75M
MXL icon
7782
CALL
MaxLinear
MXL
$6.21B
$273K ﹤0.01%
+8,000
New +$285K
PBTP icon
7783
Invesco 0-5 Yr US TIPS ETF
PBTP
$116M
$273K ﹤0.01%
10,419
-9,872
-49% -$257K
XPP icon
7784
CALL
ProShares Ultra FTSE China 50 of PROSHARES TRUST
XPP
$9.09M
$273K ﹤0.01%
+3,800
New +$313K
AKUS
7785
DELISTED
Akouos Inc
AKUS
$273K ﹤0.01%
+19,707
New +$359K
ABCL icon
7786
CALL
AbCellera Biologics
ABCL
$2.85B
$272K ﹤0.01%
+8,000
New +$319K
GEL icon
7787
CALL
Genesis Energy
GEL
$1.9B
$272K ﹤0.01%
29,100
+8,800
+43% +$66.8K
PRO
7788
DELISTED
PROS Holdings
PRO
$272K ﹤0.01%
6,402
-2,493
-28% -$114K
TRHC
7789
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$272K ﹤0.01%
5,921
-12,608
-68% -$602K
POLY
7790
DELISTED
Plantronics, Inc.
POLY
$272K ﹤0.01%
6,993
-21,463
-75% -$806K
ACLS icon
7791
PUT
Axcelis
ACLS
$4.1B
$271K ﹤0.01%
6,600
-3,500
-35% -$131K
CACI icon
7792
CALL
CACI
CACI
$14.3B
$271K ﹤0.01%
+1,100
New +$263K
DNOW icon
7793
DNOW Inc
DNOW
$3.01B
$271K ﹤0.01%
+26,899
New +$263K
KFRC icon
7794
Kforce
KFRC
$1.04B
$271K ﹤0.01%
+5,067
New +$245K
LAB icon
7795
CALL
Standard BioTools
LAB
$310M
$271K ﹤0.01%
59,900
-22,400
-27% -$123K
THRY icon
7796
Thryv Holdings
THRY
$95.5M
$271K ﹤0.01%
+11,580
New +$234K
MNTV
7797
PUT
DELISTED
Momentive Global Inc. Common Stock
MNTV
$271K ﹤0.01%
+14,800
New +$333K
DRNA
7798
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$271K ﹤0.01%
10,592
-18,426
-63% -$471K
CELH icon
7799
Celsius Holdings
CELH
$6.89B
$270K ﹤0.01%
16,857
-110,061
-87% -$2.07M
DAO
7800
Youdao
DAO
$2.19B
$270K ﹤0.01%
11,351
+3,423
+43% +$109K

Similar funds

Jane Street's Q1 2021 Portfolio in Review

As of Q1 2021, Jane Street held 10,046 positions worth $201B, up 1.1% from $199B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jane Street's Q1 2021 filing shows 2,632 new, 3,317 increased, 3,042 reduced and 1,017 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 3,305,886 shares worth $430M. The largest sale was Tesla, an estimated $1.54B.

By sector, the portfolio is most concentrated in Consumer Discretionary at 2.8% of assets, down from 3.3% a quarter earlier, followed by Communication Services and Technology.

  • Jane Street's largest Q1 2021 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 3,305,886 shares worth $430M.
  • Jane Street added most to Baidu in Q1 2021, an estimated $1.35B increase.
  • Jane Street's biggest Q1 2021 reduction was Tesla, cutting an estimated $1.54B.
  • Jane Street fully exited iShares MSCI Emerging Markets ETF in Q1 2021, selling an estimated $586M.
  • Jane Street's ten largest holdings make up 32% of its $201B portfolio in Q1 2021.
  • Jane Street opened 2,632 new positions and closed 1,017 in Q1 2021.
  • Jane Street's portfolio value rose 1.1% quarter-over-quarter to $201B.

Based on Jane Street's 13F filing for Q1 2021, filed 18 May 2021.